Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
There is an urgent need to understand how SARS-CoV-2 infects the airway epithelium and in a subset of individuals leads to severe illness or death. Induced pluripotent stem cells (iPSCs) provide a near limitless supply of human cells that can be differentiated into cell types of interest, including airway epithelium, for disease modeling. We present a human iPSC-derived airway epithelial platform, composed of the major airway epithelial cell types, that is permissive to SARS-CoV-2 infection. Subsets of iPSC-airway cells express the SARS-CoV-2 entry factors angiotensin-converting enzyme 2 ( ACE2), and transmembrane protease serine 2 ( TMPRSS2). Multiciliated cells are the primary initial target of SARS-CoV-2 infection. On infection with SARS-CoV-2, iPSC-airway cells generate robust interferon and inflammatory responses, and treatment with remdesivir or camostat mesylate causes a decrease in viral propagation and entry, respectively. In conclusion, iPSC-derived airway cells provide a physiologically relevant in vitro model system to interrogate the pathogenesis of, and develop treatment strategies for, COVID-19 pneumonia.
Article activity feed
-
-
SciScore for 10.1101/2021.07.06.451340: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding Manual quantification of N+ cells were performed by distributing 10-15 images of iPSC-airway infected with SARS-CoV-2 stained with DAPI and N (>200 cells/image) to 5 blinded scorers. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The antibodies used were; anti-SARS-CoV nucleoprotein (N) antibody (rabbit polyclonal, 1:2500, Rockland Immunochemicals, Cat #200-401-A50), anti-α-TUBULIN antibody (mouse monoclonal, 1:500 sigma cat# T6199), and anti-MUC5B antibody (mouse monoclonal, Santa Cruz Biotechnology, 1:500 anti-SARS-CoV nucleoprotein ( N )sugges…SciScore for 10.1101/2021.07.06.451340: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding Manual quantification of N+ cells were performed by distributing 10-15 images of iPSC-airway infected with SARS-CoV-2 stained with DAPI and N (>200 cells/image) to 5 blinded scorers. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The antibodies used were; anti-SARS-CoV nucleoprotein (N) antibody (rabbit polyclonal, 1:2500, Rockland Immunochemicals, Cat #200-401-A50), anti-α-TUBULIN antibody (mouse monoclonal, 1:500 sigma cat# T6199), and anti-MUC5B antibody (mouse monoclonal, Santa Cruz Biotechnology, 1:500 anti-SARS-CoV nucleoprotein ( N )suggested: Noneanti-α-TUBULINsuggested: (Sigma-Aldrich Cat# T6199, RRID:AB_477583)anti-MUC5Bsuggested: NoneNext, cells were washed with PBS three times (5 minutes, room temperature), and incubated with secondary antibody (AlexaFluor 546 AffiniPure Donkey Anti-mouse IgG (H+L), 1:500, and AlexFluor 647 donkey anti-mouse IgG (H+L) 1:500, Jackson ImmunoResearch) for 2 hours at room temperature. Anti-mouse IgGsuggested: NoneTo determine cellular tropism, Z-stack images of the infected transwells stained with either anti-SARS-CoV-2 N and α antibodies or anti-SARS-CoV-2 N and anti-mucin 5B antibodies were taken on Nikon Eclipse NiE. anti-SARS-CoV-2 N and αsuggested: Noneanti-SARS-CoV-2 Nsuggested: Noneanti-mucin 5Bsuggested: NoneAnti-MUC5AC (Abcam cat# ab198254) was applied and visualized with anti-rabbit NP (Roche) and anti-NP-AP (Roche) and detected with Discovery Yellow (Roche); counter stained with hematoxylin, rinsed with detergent, dehydrated, and cover-slipped with permanent mounting media. Anti-MUC5ACsuggested: (LSBio (LifeSpan Cat# LS-B1927-50, RRID:AB_1128083)Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 propagation and titration: SARS-CoV-2 stocks (isolate USA_WA1/2020, kindly provided by CDC’s Principal Investigator Natalie Thornburg and the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)) were grown in Vero E6 cells (ATCC CRL-1586) cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 2% fetal calf serum (FCS), penicillin (50 U/mL), and streptomycin (50 mg/mL) and titrated as described previously38. Vero E6suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Custom configured targets include: CCL2/JE/MCP-1, CXCL-9/MIG, CXCL10/IP-10/CRG-2, GM-CSF, IFNβ, IL-6, TNFα, TRAIL/TNFSF10 CCL2/JE/MCP-1suggested: NoneSoftware and Algorithms Sentences Resources Each image analyzed using ImageJ and DAPI+ nuclei and N+ cells were quantified with the multi-point tool. ImageJsuggested: (ImageJ, RRID:SCR_003070)Mean fluorescence intensity was measured to calculate final concentration in pg/mL using Bioplex200 and Bioplex Manager 5 software (Biorad). Bioplex200suggested: NoneBioplexsuggested: (BioPlex, RRID:SCR_016144)The quality of the raw data was assessed using FastQC v.0.11.774. FastQCsuggested: (FastQC, RRID:SCR_014583)The sequence reads were aligned to a combination of the human genome reference (GRCh38) and the SARS-CoV-2 reference (NC_045512) using STAR v. STARsuggested: (STAR, RRID:SCR_004463)Counts per gene were summarized using the featureCounts function from the subread package v.1.6.276. featureCountssuggested: (featureCounts, RRID:SCR_012919)subreadsuggested: (Subread, RRID:SCR_009803)The edgeR package v. edgeRsuggested: (edgeR, RRID:SCR_012802)The limma package v. limmasuggested: (LIMMA, RRID:SCR_010943)Differentially expressed genes for each comparison were visualized using Glimma v. Glimmasuggested: (Glimma, RRID:SCR_017389)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:This study is not without limitations. The iPSC-airway epithelium is transcriptionally similar to primary airway epithelium and can be used to functionally model diseases such as cystic fibrosis (CF) in vitro40. However, iPSC-derived cells differentiated into many cell types of different organs tend to be more fetal or immature than their endogenous counterparts in adults65–67, and there may be differences including receptor expression and cell type distributions. Whether our model reflects a more fetal or pediatric response to SARS-CoV-2 will require further investigation. Another limitation of this model is that the epithelial response is studied in isolation, and the complex interplay between epithelial, immune, interstitial, and endothelial cells that leads to COVID-19 pneumonia is not captured in our model. However, the iPSC system offers a reductionist, physiologically relevant model system to study the intrinsic epithelial response and provides key insights into the initial stages of COVID-19. Furthermore, given the clinical spectrum of disease severity caused by SARS-CoV-2 infection there is pressing need to further understand the mechanisms that lead to serve disease. Numerous genes, variants and pathways are implicated in modulating the response to infection and require further investigation15, 16. This iPSC-based platform, coupled with gene-editing technology, opens up future directions to evaluate the mechanisms of the airway response to SARS-CoV-2 response.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 34, 35 and 39. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-